Congratulations to Eric Rubin who was recently elected to the National Academy of Medicine (link) for “pioneering bacterial genetic tools being used to create the next generation of anti-tuberculosis drugs.”
Members celebrated the 10-year anniversary of the TBDA with a commentary published in Nature Medicine about the mission, advantages, and disadvantages of the collaboration model, scientific contributions, and medical contributions.
